Letter

Switching prescription drugs to over the counter: Over the counter licensing is linked to direct to consumer advertising

BMJ 2005; 330 doi: 10.1136/bmj.330.7496.906 (Published 14 April 2005)
Cite this as: BMJ 2005;330:906.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Robert G Bunney (robert.bunney@gp-L83073.nhs.uk), general practitioner
  1. Brannam Medical Centre, Barnstaple EX32 8GP

    EDITOR—Cohen et al ask what is driving increased availability of drugs over the counter.1 I believe that the main reason the manufacturers of simvastatin have lobbied (successfully) for permission to sell a 10 mg dose over the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular